{"id":"W2946175247","doi":"10.1016/j.cgh.2019.05.013","title":"Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases","year":2019,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; Toronto Liver Centre; University of Alberta","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Deutsche Forschungsgemeinschaft; University of Birmingham; National Institute for Health and Care Research; University Hospitals Birmingham NHS Foundation Trust; Wellcome Trust","keywords":"Vedolizumab; Medicine; Primary sclerosing cholangitis; Internal medicine; Gastroenterology; Liver transplantation; Cohort; Inflammatory bowel disease; Ulcerative colitis; Clinical endpoint; Bilirubin; Alkaline phosphatase; Transplantation; Clinical trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009151608,0.0001142777,0.0005383107,0.00007232871,0.00002250833,0.000003143039,0.00004720081,0.0001249192,0.00001574499],"category_scores_gemma":[0.00006493966,0.00009040577,0.00005146927,0.00002718218,0.0004555973,0.00006571276,0.0001059954,0.0002458331,0.000003147582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001344789,"about_ca_system_score_gemma":0.00004152426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001331208,"about_ca_topic_score_gemma":0.000006870979,"domain_scores_codex":[0.9989235,0.0002010893,0.0003382135,0.0002454855,0.00006179048,0.000229906],"domain_scores_gemma":[0.9992908,0.0002491353,0.000113431,0.000164368,0.00004126487,0.0001410661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006273746,0.0005973205,0.9914374,0.0004388951,0.00008314659,0.00002752959,0.00002444778,1.184765e-7,0.00001901003,0.00002736237,0.00002340952,0.001047606],"study_design_scores_gemma":[0.01203783,0.004082571,0.9834213,0.000170507,0.0001480564,0.00001484579,0.000009876907,0.00001747347,0.000004627205,0.0000267917,0.00001733029,0.00004874639],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989589,0.0004040654,0.000004502788,0.00009827886,0.0001148444,0.0003630064,0.000009003317,0.00001165458,0.0000357076],"genre_scores_gemma":[0.9984044,0.0002313558,0.00006222753,0.001232738,0.00001902989,0.00000715885,0.00002603806,0.000009583153,0.000007489741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008016062,"threshold_uncertainty_score":0.368664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00619690842481883,"score_gpt":0.2391362441734501,"score_spread":0.2329393357486313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}